ClinicalTrials.gg
RecruitingNCT06237283Updated Feb 2, 2024

Effects of Early Postoperative Showering After Coronary Artery Bypass Grafting Using Bilateral Internal Thoracic Artery

An interventional study of Early shower in Wounds and Injuries and Wound Infection, sponsored by Sejong General Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2024-02-02.

Sponsored by Sejong General Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The study to evaluate effects of early postoperative showering after coronary artery bypass grafting using bilateral internal thoracic artery

02

Conditions studied

  • Wounds and Injuries
  • Wound Infection
03

In context

Wounds and Injuries

2,217 studies on the registry are indexed under Wounds and Injuries; 441 are open to participants now.

This study's planned enrollment of 200 is above the median of 70 across 1,424 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Sejong General Hospital is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18
  • Patients who underwent coronary bypass grafting with bilateral internal thoracic artery through median sternotomy
  • Patients whose all drains or pacing wires are removed

Exclusion criteria

Exclusion Criteria:

  • Concomitant operation
  • Redo-surgery
  • prolonged intensive care unit stay (more than 4 days) due to serious complications after surgery
  • open wounds
  • active infection
  • prolonged drains
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Early shower

    Start shower after drain removal

    Behavioral: Early shower

  • No intervention
    Late shower

    Start shower after wound stitches are removed

Interventions

  • BehavioralEarly shower

    Start shower after drain removal

06

What researchers measure

Primary outcomes

  1. Rate of deep sternal wound infection

    Time frame: until 1 months after discharge

  2. Rate of superficial sternal wound infection

    Time frame: until 1 months after discharge

  3. Rate of wound dehiscence

    Time frame: until 1 months after discharge

Secondary outcomes

  1. Patient satisfaction

    questionnaire

    Time frame: at 1st outpatient clinic visit

  2. Rate of mortality

    Time frame: until 1 months after discharge

  3. Rate of stroke

    Time frame: until 1 months after discharge

  4. Rate of respiratory complications

    Time frame: until 1 months after discharge

  5. Rate of bleeding requiring reoperation

    Time frame: until 1 months after discharge

  6. Rate of low cardiac output syndrome

    Time frame: until 1 months after discharge

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06237283
Lead sponsor
Sejong General Hospital
Responsible party
Sponsor
First posted
Feb 1, 2024
Start date
Jan 3, 2024
Primary completion
Mar 1, 2025 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Feb 2, 2024

Study contacts

HEEMOON LEE
Contact
rhythmists@gmail.com
82-10-9083-6249
KyuWon Kang
Contact
rbdnjs9707@daum.net
82-10-2276-8479

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion